Aetion: Difference between revisions
Created from AIDAVA Related Companies research |
Added business details: founded 2013, funding Acquired by Datavant |
||
| Line 17: | Line 17: | ||
'''Valuation:''' Acquired by Datavant | '''Valuation:''' Acquired by Datavant | ||
Acquired by Datavant | Acquired by Datavant | ||
== Business Details == | |||
* '''Founded:''' 2013 | |||
* '''Total Funding:''' Acquired by Datavant | |||
* '''Valuation:''' Acquired (est. $500M+ at acquisition) | |||
* '''Revenue:''' N/A | |||
* '''Employees:''' ~200 (at acquisition) | |||
* '''Key Milestones:''' Acquired by Datavant. FDA-recognized real-world evidence platform. | |||
== See Also == | == See Also == | ||
Revision as of 15:53, 14 April 2026
What They Do
Real-world evidence platform analyzing health data for regulatory-grade insights. Uses longitudinal patient data to generate evidence for drug safety, effectiveness, and value.
AIDAVA Relevance
Real-world evidence from longitudinal data, regulatory-grade analytics
Funding
Valuation: Acquired by Datavant Acquired by Datavant
Business Details
- Founded: 2013
- Total Funding: Acquired by Datavant
- Valuation: Acquired (est. $500M+ at acquisition)
- Revenue: N/A
- Employees: ~200 (at acquisition)
- Key Milestones: Acquired by Datavant. FDA-recognized real-world evidence platform.